CareDx, Inc (CDNA)
NASDAQ: CDNA · IEX Real-Time Price · USD
19.01
+0.14 (0.74%)
Jul 26, 2024, 4:30 PM EDT - Market closed
CareDx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 275.11 | 280.32 | 321.79 | 296.4 | 192.19 | 127.07 | Upgrade
|
| Revenue Growth (YoY) | -13.93% | -12.89% | 8.57% | 54.22% | 51.25% | 65.95% | Upgrade
|
| Cost of Revenue | 101.97 | 102 | 112.21 | 97.39 | 63.12 | 45.46 | Upgrade
|
| Gross Profit | 173.14 | 178.33 | 209.58 | 199.01 | 129.08 | 81.61 | Upgrade
|
| Selling, General & Admin | 195.98 | 200.5 | 196.42 | 152.21 | 102.66 | 75.43 | Upgrade
|
| Research & Development | 76.22 | 81.87 | 90.39 | 76.53 | 48.94 | 30.71 | Upgrade
|
| Operating Expenses | 272.2 | 282.37 | 286.81 | 228.73 | 151.61 | 106.15 | Upgrade
|
| Operating Income | -99.06 | -104.04 | -77.23 | -29.73 | -22.53 | -24.53 | Upgrade
|
| Interest & Investment Income | 9.38 | 6.94 | 4.15 | 1.29 | 0.27 | 0.99 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.38 | -0.15 | -1.58 | -0.78 | -2.31 | -0.4 | Upgrade
|
| EBT Excluding Unusual Items | -90.05 | -97.25 | -74.66 | -29.22 | -24.56 | -23.95 | Upgrade
|
| Merger & Restructuring Charges | -3.02 | -3.02 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.11 | 6.43 | -1.57 | -2.87 | - | - | Upgrade
|
| Legal Settlements | -96.3 | -96.3 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 4.81 | - | Upgrade
|
| Pretax Income | -183.26 | -190.14 | -76.23 | -32.09 | -19.75 | -23.95 | Upgrade
|
| Income Tax Expense | -0.07 | 0.14 | 0.38 | -1.43 | -1.04 | -1.98 | Upgrade
|
| Earnings From Continuing Operations | -183.19 | -190.28 | -76.61 | -30.66 | -18.71 | -21.97 | Upgrade
|
| Net Income | -183.19 | -190.28 | -76.61 | -30.66 | -18.71 | -21.97 | Upgrade
|
| Net Income to Common | -183.19 | -190.28 | -76.61 | -30.66 | -18.71 | -21.97 | Upgrade
|
| Shares Outstanding (Basic) | 53 | 54 | 53 | 52 | 46 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 54 | 53 | 52 | 46 | 42 | Upgrade
|
| Shares Change (YoY) | -0.38% | 0.83% | 2.07% | 12.39% | 10.27% | 18.27% | Upgrade
|
| EPS (Basic) | -3.44 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | Upgrade
|
| EPS (Diluted) | -3.44 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | Upgrade
|
| Free Cash Flow | -41.43 | -26.73 | -46.47 | -32.85 | 26.32 | -4.97 | Upgrade
|
| Free Cash Flow Per Share | -0.78 | -0.50 | -0.87 | -0.63 | 0.57 | -0.12 | Upgrade
|
| Gross Margin | 62.94% | 63.61% | 65.13% | 67.14% | 67.16% | 64.23% | Upgrade
|
| Operating Margin | -36.01% | -37.12% | -24.00% | -10.03% | -11.72% | -19.31% | Upgrade
|
| Profit Margin | -66.59% | -67.88% | -23.81% | -10.34% | -9.74% | -17.29% | Upgrade
|
| Free Cash Flow Margin | -15.06% | -9.54% | -14.44% | -11.08% | 13.70% | -3.91% | Upgrade
|
| EBITDA | -84.28 | -89.66 | -65.64 | -20.93 | -15.52 | -19.01 | Upgrade
|
| EBITDA Margin | -30.63% | -31.98% | -20.40% | -7.06% | -8.08% | -14.96% | Upgrade
|
| D&A For EBITDA | 14.78 | 14.39 | 11.6 | 8.8 | 7.01 | 5.52 | Upgrade
|
| EBIT | -99.06 | -104.04 | -77.23 | -29.73 | -22.53 | -24.53 | Upgrade
|
| EBIT Margin | -36.01% | -37.12% | -24.00% | -10.03% | -11.72% | -19.31% | Upgrade
|
| Revenue as Reported | 275.11 | 280.32 | 321.79 | 296.4 | 192.19 | 127.07 | Upgrade
|
Source: S&P Capital IQ. Standard template.